FULVESTRANT POWDER

Q: How should Fulvestrant Powder be stored to ensure its stability?

A: Fulvestrant Powder should be kept in a cool, dry location and protected from light. Ideally, it remains packaged in sealed double PE bags with an outer aluminum foil bag to preserve its quality and extend shelf life up to two years.

Q: What is the principal medical use of Fulvestrant Powder?

A: This powder is used primarily as an antineoplastic agent to treat hormone receptor-positive metastatic breast cancer in postmenopausal women, helping to block estrogen receptor activity and slow tumor growth.

Q: When is Fulvestrant Powder recommended for pharmaceutical applications?

A: Fulvestrant Powder is indicated for use when manufacturing medications intended for hormone receptor-positive metastatic breast cancer in postmenopausal women, as per the prescribed pharmacopoeia standards.

Q: Where can I obtain molecular and structural formula details of Fulvestrant Powder?

A: The molecular formula, C32H47F5O3S, and the molecular weight (606.77 g/mol) are provided, while the detailed structural formula can be supplied upon request from authorized distributors or manufacturers.

Q: What precautions should be taken when handling Fulvestrant Powder?

A: It is essential to avoid inhalation and contact with eyes or skin. Personal protective equipment, such as gloves, masks, and protective clothing, should always be used during handling to minimize health risks.

Q: What are the benefits of using Fulvestrant Powder with USP/EP compliance?

A: Fulvestrant Powder that complies with USP/EP pharmacopoeia standards ensures high purity, consistent quality, and safety, making it suitable for regulated pharmaceutical manufacturing and patient therapies.